Literature DB >> 25481465

Anosognosia in Alzheimer's disease: diagnosis, frequency, mechanism and clinical correlates.

Sergio E Starkstein1.   

Abstract

Anosognosia is present in a large proportion of patients with mild Alzheimer's disease (AD), and its frequency increases with the progression of the illness. Several instruments have been validated to assess anosognosia in AD, but there is no consensus regarding the best diagnostic strategy. Anosognosia in AD is a significant predictor of apathy and is significantly related to lower depression and anxiety scores, more severe caregiver burden and dangerous behaviours. Studies using different imaging modalities have demonstrated an association between anosognosia and dysfunction in frontal, temporomedial and temporoparietal regions. The mechanism of anosognosia remains unknown, but it has been explained as a consequence of deficits of encoding and updating biographical memory, and dysfunction of comparator, executive and metacognitive systems.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Anosognosia; Awareness; Insight; Self-knowledge

Mesh:

Year:  2014        PMID: 25481465     DOI: 10.1016/j.cortex.2014.07.019

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  49 in total

Review 1.  Anosognosia in Dementia.

Authors:  Robert S Wilson; Joel Sytsma; Lisa L Barnes; Patricia A Boyle
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

2.  Awareness of cognitive impairment in individuals with essential tremor.

Authors:  Martina Azar; Elodie Bertrand; Elan D Louis; Edward Huey; Kathleen Collins; Brittany Rohl; Stephanie Cosentino
Journal:  J Neurol Sci       Date:  2017-04-07       Impact factor: 3.181

3.  Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment.

Authors:  Emily C Edmonds; Alexandra J Weigand; Kelsey R Thomas; Joel Eppig; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2018-09       Impact factor: 2.892

4.  Disconnection Between Self-Reported and Objective Cognitive Impairment in Obstructive Sleep Apnea.

Authors:  Katia Gagnon; Andrée-Ann Baril; Jacques Montplaisir; Julie Carrier; Louis De Beaumont; Caroline D'Aragon; Sirin Chami; Sandra Pelleieux; Judes Poirier; Serge Gauthier; Chantal Lafond; Jean-François Gagnon; Nadia Gosselin
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

5.  Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease.

Authors:  Patrizia Vannini; Rebecca Amariglio; Bernard Hanseeuw; Keith A Johnson; Donald G McLaren; Jasmeer Chhatwal; Alvaro Pascual-Leone; Dorene Rentz; Reisa A Sperling
Journal:  Neuropsychologia       Date:  2017-04-03       Impact factor: 3.139

Review 6.  [Dementia - View of sufferers and their relatives].

Authors:  Rainer Schaub; Heike von Lützau-Hohlbein
Journal:  Z Gerontol Geriatr       Date:  2017-10-09       Impact factor: 1.281

7.  Informant Report of Financial Capacity for Individuals With Chronic Acquired Brain Injury: An Assessment of Informant Accuracy.

Authors:  Preeti Sunderaraman; Stephanie Cosentino; Karen Lindgren; Angela James; Maria Schultheis
Journal:  J Head Trauma Rehabil       Date:  2018 Nov/Dec       Impact factor: 2.710

8.  Evolution of anosognosia in alzheimer's disease and its relationship to amyloid.

Authors:  Bernard J Hanseeuw; Matthew R Scott; Sietske A M Sikkes; Michael Properzi; Jennifer R Gatchel; Eric Salmon; Gad A Marshall; Patrizia Vannini
Journal:  Ann Neurol       Date:  2019-12-05       Impact factor: 10.422

9.  Alzheimer's and Consciousness: How Much Subjectivity Is Objective?

Authors:  Vladan Bajic; Natasa Misic; Ivana Stankovic; Bozidarka Zaric; George Perry
Journal:  Neurosci Insights       Date:  2021-07-20

10.  Pathological correlates of impaired self-awareness of memory function in Alzheimer's disease.

Authors:  Geoffroy Gagliardi; Madeline Kuppe; Cristina Lois; Bernard Hanseeuw; Patrizia Vannini
Journal:  Alzheimers Res Ther       Date:  2021-06-25       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.